Colestipol tablets in adolescents with familial hypercholesterolaemia

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 9, 1996, Pages 1080-1082

  Tonstad, S ^a   Ose, L ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adolescence; Colestipol; Hypercholesterolaemia; Tablets

Indexed keywords

CHOLESTEROL; COLESTIPOL; COLESTYRAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DYSPEPSIA; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FLATULENCE; HETEROZYGOTE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PALATABILITY; PRIORITY JOURNAL; TABLET;

EID: 0029785513     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14221.x     Document Type: Article

References (11)

1. West RJ, Lloyd JK. Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine. Lancet 1980;ii:873-5
2. Tonstad S, Sivertsen M, Aksnes L, Ose L. Low dose colestipol in adolescents with familial hypercholesterolaemia. Arch Dis Child 1996;74:157-60
3. Tonstad S, Bing RF, Frohlich J, Karpov Y, Ose L, Romics L, et al. Effectiveness of colestipol tablets vs granules in patients with moderate to severe hypercholesterolaemia. Clin Drug Invest 1995;10:257-63
4. Leren TP, Solberg K, Rodningen OK, Tonstad S, Ose L. Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects. Atherosclerosis 1994;111:175-82
5. Leren TP, Sundvold H, Rodningen OK, Tonstad S, Solberg K, Ose L, et al. Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia. Hum Genet 1995;95:671-6
6. Himes JH, Dietz WH. Guidelines for overweight in adolescent preventive services: recommendations from an expert committee. Am J Clin Nutr 1994;59:307-16
7. Insull W, Davidson MH, Demke DM, Dujovne CA, Eckert SM, Ginsberg D, et al. The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients. Atherosclerosis 1995;112:223-35
8. Liacouras CA, Coates PM, Gallagher PR, Conner JA. Use of cholestyramine in the treatment of children with familial combined hyperlipidemia. J Pediatr 1993;122:477-82
9. Glueck CJ, Rallat RW, Mellies M, Tsang RC. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin. Pediatrics 1976;57:68-74
10. Tonstad S, Leren TP, Sivertsen M, Ose L. Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway. Arterioscler Thromb Vasc Biol 1995;15:1009-14
11. Levine GN, Keaney JF Jr., Vita JA. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med 1995;332:512-21